Multiple sclerosis de novo CNS IgG synthesis
- 1 November 1980
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 30 (11) , 1155
- https://doi.org/10.1212/wnl.30.11.1155
Abstract
ACTH gel and corticosteroids were given to 28 clinically definite multiple sclerosis (MS) patients to determine whether de novo central nervous system (CNS) IgG synthesis (rate and cerebrospinal fluid [CSF] IgG oligoclonal bands) could be eradicated. The most effective treatments were ACTH gel and ACTH gel followed by prednisone; all 11 patients had a significant reduction in rate (p < 0.051, which became normal in eight patients (< 3.3 mg per day). In order of effectiveness, the other drugs used were: dexamethasone or prednisone given orally, and hydrocortisone administered intrathecally. For most treatments, reduction of the rate of CNS IgG synthesis occurred within days and persisted for months after cessation of treatment. The MS CNS immune reaction was not eradicated when IgG synthesis rate became normal, because CSF IgG oligoelonal bands persisted. None of the chronic progressive, severely disabled patients demonstrated significant change in neurologic function or persistent adverse effects.This publication has 10 references indexed in Scilit:
- Prolonged effects of large‐dose methylprednisolone infusion in multiple sclerosisNeurology, 1980
- Multiple sclerosisNeurology, 1980
- Myelinotoxic activity on tadpole optic nerve of cerebrospinal fluid from patients with optic neuritisNeurology, 1979
- Methodology tor analyzing clinical neurological data: ACTH in multiple sclerosisClinical Pharmacology & Therapeutics, 1978
- Modifications of the cerebrospinal fluid IgG concentrations in patients with multiple sclerosis treated with intrathecal steroidsZeitschrift für Neurologie, 1978
- Multiple Sclerosis Cerebrospinal Fluid Produces Myelin Lesions in Tadpole Optic NervesNew England Journal of Medicine, 1976
- Immunofixation electrophoretic techniques applied to identification of proteins in serum and cerebrospinal fluid.Clinical Chemistry, 1976
- Glucocorticosteroid Therapy: Mechanisms of Action and Clinical ConsiderationsAnnals of Internal Medicine, 1976
- Drug Spotlight ProgramAnnals of Internal Medicine, 1974
- Subarachnoid Distribution of Drugs after Lumbar InjectionNew England Journal of Medicine, 1962